CapitaLand Group has officially opened Geneo, a S$1.4b life sciences and innovation hub at Singapore Science Park, marking a pivotal moment in the park’s rejuvenation. The opening ceremony, officiated by Minister Tan See Leng, highlighted the move of anchor tenant A*STAR into the hub, reinforcing Singapore’s position in the biomedical sciences sector.
Geneo, jointly owned by CapitaLand Development and CapitaLand Ascendas REIT, spans three properties with a total gross floor area of approximately 180,600 square metres. It offers purpose-built infrastructure for biomedical research and development, flexible laboratories, and Grade A business park workspaces. Jonathan Yap, CEO of CapitaLand Development, described Geneo as a “defining milestone” in the park’s rejuvenation, emphasising its role in supporting the full innovation cycle.
The hub has attracted world-class tenants, including Barry Callebaut, Chugai Pharmabody Research, Henkel, and NSG Bio, spanning industries from biotech to pharmaceutical R&D. William Tay, CEO of the manager of CapitaLand Ascendas REIT, noted the strong tenancy demand from leading companies, reinforcing the hub’s position in Singapore’s life sciences real estate market.
Geneo’s infrastructure includes wet labs, coworking laboratory spaces, and smart building systems, fostering cross-disciplinary collaborations. The hub also features Bridge+ Geneo, Southeast Asia’s largest coworking laboratory, supporting life science enterprises from discovery to industry deployment.
Sustainability is at the core of Geneo, with all properties achieving the Building and Construction Authority’s Green Mark Platinum rating. The hub also supports community initiatives, such as the SSP-ACE! Programme, offering students from underserved backgrounds opportunities to explore STEM pathways.
